Skip to main content
Contact Us
Subscribe
E-Edition
79°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Accolade Inc
(NQ:
ACCD
)
7.890
-1.300 (-14.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Accolade Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
June 30, 2023
Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
Via
Benzinga
NVIDIA To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Friday
June 30, 2023
Truist Securities boosted the price target for BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from $125 to $140. Truist Securities analyst Robyn Karnauskas maintained a Buy rating. BioMarin Pharmaceutical...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 30, 2023
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!
Via
InvestorPlace
Accolade: Q1 Earnings Insights
June 29, 2023
Via
Benzinga
Earnings Outlook For Accolade
June 28, 2023
Via
Benzinga
What 12 Analyst Ratings Have To Say About Accolade
June 22, 2023
Via
Benzinga
What 12 Analyst Ratings Have To Say About Accolade
May 24, 2023
Via
Benzinga
Shareholders Like What These 2 Companies Just Told Them
June 29, 2023
Good financial results have investors feeling bullish about their prospects.
Via
The Motley Fool
Accolade Announces Results for Fiscal First Quarter 2024
June 29, 2023
From
Accolade, Inc.
Via
GlobeNewswire
Accolade's Financial Forecast: Anticipating Raised Guidance and Robust Revenue Growth
June 26, 2023
Needham analyst Ryan MacDonald reiterated a Buy rating on the shares of Accolade, Inc. (NASDAQ: ACCD) with a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
Accolade Earnings Perspective: Return On Capital Employed
May 03, 2023
Via
Benzinga
A Preview Of Accolade's Earnings
April 26, 2023
Via
Benzinga
Analyst Ratings for Accolade
April 21, 2023
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
May 11, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 28, 2023
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
Via
Benzinga
Analyst Expectations for Accolade's Future
March 23, 2023
Via
Benzinga
Why Shares of Accolade Soared This Week
January 13, 2023
Strong revenue growth and encouraging guidance pushed the stock up.
Via
The Motley Fool
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023
April 27, 2023
From
Accolade, Inc.
Via
GlobeNewswire
Accolade Inc. (NASDAQ: ACCD) Records 52-Week High Thursday Morning
April 27, 2023
Via
Investor Brand Network
Humana Stock Checkup Shows Healthy Growth; Profits Strong
April 25, 2023
Among its other ratings, Louisville, Ky.-based Humana boasts a 94 EPS Rating, out of 99, showing strong profit growth. Humana stock rose.
Via
Investor's Business Daily
Barrick Gold To Rally Over 47%? Here Are 10 Other Analyst Forecasts For Friday
April 21, 2023
Keybanc raised the price target for Watsco, Inc. (NYSE: WSO) from $365 to $380. Keybanc analyst Jeffrey Hammond maintained an Overweight rating. Watsco shares gained 8.3% to close at $342.93 on...
Via
Benzinga
Accolade Inc. (NASDAQ: ACCD) Records 52-Week High Wednesday Morning
April 12, 2023
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
March 23, 2023
Via
Benzinga
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
March 23, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2023
February 09, 2023
Via
Benzinga
Analyst Initiates Coverage On Accolade, Says 'Differentiated In Growing Market'
February 02, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
February 02, 2023
Via
Benzinga
Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop
January 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.